1. Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
   Daniele Fanale et al, 2022, Frontiers in Oncology CrossRef
2. Strategies for five tumour markers in the screening and diagnosis of female breast cancer
   Jun Luo et al, 2023, Frontiers in Oncology CrossRef
3. Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis
   Qingyi Wang et al, 2022, Frontiers in Oncology CrossRef